Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches
Building on the classification of the clinical phenotype and prediction of clinical trajectory
based on individual patients' autoantigen and/or autoantibody profile, cellular therapies
targeting the same autoantigen or related autoreactive cells may represent an
unprecedented opportunity to implement personalized medicine in SSc.
based on individual patients' autoantigen and/or autoantibody profile, cellular therapies
targeting the same autoantigen or related autoreactive cells may represent an
unprecedented opportunity to implement personalized medicine in SSc.
Summary
Building on the classification of the clinical phenotype and prediction of clinical trajectory based on individual patients’ autoantigen and/or autoantibody profile, cellular therapies targeting the same autoantigen or related autoreactive cells may represent an unprecedented opportunity to implement personalized medicine in SSc.
Lippincott Williams & Wilkins以上显示的是最相近的搜索结果。 查看全部搜索结果